Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06562153 · ClinicalTrials.gov registry record
fMRI Accelerated TMS Depression
A clinical trial of Depression, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06562153 is a study of Depression that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 20 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06562153, a study of Depression, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerated antidepressant transcranial magnetic stimulation (TMS) treatment.
Conditions Studied
Interventions
- OTHER Neuroimaging with Magnetic Resonance Imaging (MRI)
Study Locations (1)
South Carolina
- 30 Bee Street - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-23 |
| Est. Completion | 2026-08-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06562153
The ClinicalTrials.gov registry entry for NCT06562153 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Neuroimaging with Magnetic Resonance Imaging (MRI) is the first listed.
NCT06562153 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06562153 about?
NCT06562153 is a clinical study titled "fMRI Accelerated TMS Depression". This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerate...
What is the current status of trial NCT06562153?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-09-23. Estimated completion is 2026-08-05.
What conditions does trial NCT06562153 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT06562153?
The interventions under investigation include: Neuroimaging with Magnetic Resonance Imaging (MRI) (OTHER).
Who is sponsoring clinical trial NCT06562153?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06562153 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.